The Use of COVID-19 Vaccines in Patients with SLE

PURPOSE OF REVIEW: Three COVID-19 vaccines obtained emergency authorization from the Food and Drug Administration (FDA) and are widely used in the USA. Unfortunately, there is a paucity of evidence on the safety and efficacy of these vaccines in patients with autoimmune inflammatory rheumatic diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Wei, Gartshteyn, Yevgeniya, Ricker, Edd, Inzerillo, Sean, Murray, Shane, Khalili, Leila, Askanase, Anca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Systemic Lupus Erythematosus (G Tsokos, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586600/
https://www.ncbi.nlm.nih.gov/pubmed/34767100
http://dx.doi.org/10.1007/s11926-021-01046-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586600/
https://www.ncbi.nlm.nih.gov/pubmed/34767100
http://dx.doi.org/10.1007/s11926-021-01046-2

Ejemplares similares